115 related articles for article (PubMed ID: 9675317)
1. Distribution of perlecan in mouse hippocampus following intracerebroventricular kainate injections.
Shee WL; Ong WY; Lim TM
Brain Res; 1998 Jul; 799(2):292-300. PubMed ID: 9675317
[TBL] [Abstract][Full Text] [Related]
2. Characterization of proteoglycans synthesized by murine embryonal carcinoma cells (P19) reveals increased expression of perlecan (heparan sulfate proteoglycan) during neuronal differentiation.
Sekiguchi RT; Potter-Perigo S; Braun K; Miller J; Ngo C; Fukuchi K; Wight TN; Kimata K; Snow AD
J Neurosci Res; 1994 Aug; 38(6):670-86. PubMed ID: 7807583
[TBL] [Abstract][Full Text] [Related]
3. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.
Snow AD; Sekiguchi RT; Nochlin D; Kalaria RN; Kimata K
Am J Pathol; 1994 Feb; 144(2):337-47. PubMed ID: 8311117
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the heparan sulfate proteoglycan, perlecan, by injury and interleukin-1alpha.
García de Yébenes E; Ho A; Damani T; Fillit H; Blum M
J Neurochem; 1999 Aug; 73(2):812-20. PubMed ID: 10428080
[TBL] [Abstract][Full Text] [Related]
5. Localization of perlecan (or a perlecan-related macromolecule) to isolated microglia in vitro and to microglia/macrophages following infusion of beta-amyloid protein into rodent hippocampus.
Miller JD; Cummings J; Maresh GA; Walker DG; Castillo GM; Ngo C; Kimata K; Kinsella MG; Wight TN; Snow AD
Glia; 1997 Oct; 21(2):228-43. PubMed ID: 9336237
[TBL] [Abstract][Full Text] [Related]
6. A light and electron microscopic study of NG2 chondroitin sulfate proteoglycan-positive oligodendrocyte precursor cells in the normal and kainate-lesioned rat hippocampus.
Ong WY; Levine JM
Neuroscience; 1999; 92(1):83-95. PubMed ID: 10392832
[TBL] [Abstract][Full Text] [Related]
7. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
Vischer P; Feitsma K; Schön P; Völker W
Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
[TBL] [Abstract][Full Text] [Related]
8. Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain.
Verbeek MM; Otte-Höller I; van den Born J; van den Heuvel LP; David G; Wesseling P; de Waal RM
Am J Pathol; 1999 Dec; 155(6):2115-25. PubMed ID: 10595940
[TBL] [Abstract][Full Text] [Related]
9. Effects of glutamate receptor activation on NG2-glia in the rat optic nerve.
Hamilton N; Hubbard PS; Butt AM
J Anat; 2009 Feb; 214(2):208-18. PubMed ID: 19207982
[TBL] [Abstract][Full Text] [Related]
10. Novel purification and detailed characterization of perlecan isolated from the Engelbreth-Holm-Swarm tumor for use in an animal model of fibrillar A beta amyloid persistence in brain.
Castillo GM; Cummings JA; Ngo C; Yang W; Snow AD
J Biochem; 1996 Aug; 120(2):433-44. PubMed ID: 8889831
[TBL] [Abstract][Full Text] [Related]
11. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease.
Snow AD; Kinsella MG; Parks E; Sekiguchi RT; Miller JD; Kimata K; Wight TN
Arch Biochem Biophys; 1995 Jun; 320(1):84-95. PubMed ID: 7793988
[TBL] [Abstract][Full Text] [Related]
12. A beta and perlecan in rat brain: glial activation, gradual clearance and limited neurotoxicity.
Holcomb LA; Gordon MN; Benkovic SA; Morgan DG
Mech Ageing Dev; 2000 Jan; 112(2):135-52. PubMed ID: 10690926
[TBL] [Abstract][Full Text] [Related]
13. Induction of P-glycoprotein expression in astrocytes following intracerebroventricular kainate injections.
Zhang L; Ong WY; Lee T
Exp Brain Res; 1999 Jun; 126(4):509-16. PubMed ID: 10422714
[TBL] [Abstract][Full Text] [Related]
14. Heparan sulfate proteoglycan (perlecan) expression by mouse embryos during acquisition of attachment competence.
Carson DD; Tang JP; Julian J
Dev Biol; 1993 Jan; 155(1):97-106. PubMed ID: 8416848
[TBL] [Abstract][Full Text] [Related]
15. Heparan sulfate proteoglycan expression in chronic cholestatic human liver diseases.
Roskams T; Rosenbaum J; De Vos R; David G; Desmet V
Hepatology; 1996 Sep; 24(3):524-32. PubMed ID: 8781318
[TBL] [Abstract][Full Text] [Related]
16. A proteoglycan that activates fibroblast growth factors during early neuronal development is a perlecan variant.
Joseph SJ; Ford MD; Barth C; Portbury S; Bartlett PF; Nurcombe V; Greferath U
Development; 1996 Nov; 122(11):3443-52. PubMed ID: 8951060
[TBL] [Abstract][Full Text] [Related]
17. Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability.
Castillo GM; Ngo C; Cummings J; Wight TN; Snow AD
J Neurochem; 1997 Dec; 69(6):2452-65. PubMed ID: 9375678
[TBL] [Abstract][Full Text] [Related]
18. Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
Castillo GM; Cummings JA; Yang W; Judge ME; Sheardown MJ; Rimvall K; Hansen JB; Snow AD
Diabetes; 1998 Apr; 47(4):612-20. PubMed ID: 9568695
[TBL] [Abstract][Full Text] [Related]
19. Activity-dependent regulation of neuronal synthesis and release of neurite-promoting heparan sulfate proteoglycans.
Sugiura M; Dow KE
Dev Biol; 1994 Jul; 164(1):102-10. PubMed ID: 7913068
[TBL] [Abstract][Full Text] [Related]
20. Expression of the basement membrane heparan sulfate proteoglycan (perlecan) in human synovium and in cultured human synovial cells.
Dodge GR; Boesler EW; Jimenez SA
Lab Invest; 1995 Nov; 73(5):649-57. PubMed ID: 7474938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
